TR200200521T2 - Parenteral cisplatin emülsiyonu. - Google Patents

Parenteral cisplatin emülsiyonu.

Info

Publication number
TR200200521T2
TR200200521T2 TR2002/00521T TR200200521T TR200200521T2 TR 200200521 T2 TR200200521 T2 TR 200200521T2 TR 2002/00521 T TR2002/00521 T TR 2002/00521T TR 200200521 T TR200200521 T TR 200200521T TR 200200521 T2 TR200200521 T2 TR 200200521T2
Authority
TR
Turkey
Prior art keywords
cisplatin
mixtures
emulsion
oil
aqueous
Prior art date
Application number
TR2002/00521T
Other languages
English (en)
Inventor
Annappa Pai Srikanth
Hanurmesh Rivankar Sangeeta
Sudhakar Kocharekar Shilpa
Original Assignee
Gautam Vinod Daftary
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gautam Vinod Daftary filed Critical Gautam Vinod Daftary
Publication of TR200200521T2 publication Critical patent/TR200200521T2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Parenteral ilaç verilmesinde düsük toksisiteye sahip sulu-yagli emülsiyon seklinde steril bir farmasötik cisplatin karisimlari tarif edilmistir. Esasen bu karisimlarin yagli fazinda cisplatinli yagli-sulu emülsiyon bulunmaktadir. Bu sinergitik karisimlarin üretim islemi tarif edilmistir. Cisplatin yagli fazda serpistirilir ve emülsiyon yapici kullanilarak sulu fazla emülsiyon yapilir. Bu karisimda belirtilen edetat, otoklavlamada ürünün renk degistirmesini önlemek ve stabilize etmek için gereken miktardadir.
TR2002/00521T 1999-07-28 2000-07-26 Parenteral cisplatin emülsiyonu. TR200200521T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN535BO1999 IN186588B (tr) 1999-07-28 1999-07-28

Publications (1)

Publication Number Publication Date
TR200200521T2 true TR200200521T2 (tr) 2002-07-22

Family

ID=11080186

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2002/00521T TR200200521T2 (tr) 1999-07-28 2000-07-26 Parenteral cisplatin emülsiyonu.

Country Status (27)

Country Link
US (1) US6572884B1 (tr)
EP (1) EP1204417B1 (tr)
JP (1) JP2003505424A (tr)
KR (1) KR20020063839A (tr)
CN (1) CN100384436C (tr)
AP (1) AP2002002384A0 (tr)
AT (1) ATE269094T1 (tr)
AU (1) AU778852B2 (tr)
BG (1) BG106446A (tr)
BR (1) BR0012796A (tr)
CA (1) CA2379815A1 (tr)
CZ (1) CZ2002268A3 (tr)
DE (1) DE60011625T2 (tr)
EA (1) EA004587B1 (tr)
ES (1) ES2223571T3 (tr)
GE (1) GEP20033046B (tr)
HU (1) HUP0202269A3 (tr)
IL (1) IL147786A0 (tr)
IN (1) IN186588B (tr)
MX (1) MXPA02002174A (tr)
NO (1) NO20020394L (tr)
NZ (1) NZ517502A (tr)
PL (1) PL352577A1 (tr)
TR (1) TR200200521T2 (tr)
WO (1) WO2001007058A2 (tr)
YU (1) YU13302A (tr)
ZA (1) ZA200201548B (tr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003057129A1 (en) * 2001-12-28 2003-07-17 Terumo Kabushiki Kaisha Blood bag system and method of inactivating pathogenic microorganisms
EP1799266A2 (en) * 2004-09-13 2007-06-27 Bharat Serums & Vaccines Ltd. Stable emulsion compositions for intravenous administration having antimicrobial preservative efficacy
MX2008008009A (es) * 2005-12-23 2008-09-12 Ajay Gupta Composicion de nutricion parenteral que contiene hierro.
US20100048607A1 (en) * 2008-08-25 2010-02-25 Chandrashekhar Kocherlakota Formulations comprising palonosetron
CN102525921B (zh) * 2012-02-06 2013-08-07 西安力邦制药有限公司 2,2’,6,6’-四异丙基-4,4’-二联苯酚脂微球制剂及其制备方法
US9164954B2 (en) * 2012-10-08 2015-10-20 The Coca-Cola Company Vending accommodation and accessibility
CN104490776B (zh) * 2014-12-26 2017-06-16 本溪恒康制药有限公司 前列地尔注射液及其制备方法
CN104490777B (zh) * 2014-12-26 2019-07-23 北京蓝丹医药科技有限公司 一种丁酸氯维地平脂肪乳及其制备方法
CN110870873A (zh) * 2019-12-18 2020-03-10 吴昱晔 一种glut12蛋白抑制剂及其制备方法和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0647559B2 (ja) * 1990-04-04 1994-06-22 ナシヨナル・サイエンス・カウンシル 改良された安定性と徐放作用を有する標的化学療法用抗癌剤エマルジョン及びその製法
US5693337A (en) * 1994-07-13 1997-12-02 Wakamoto Pharmaceutical Co., Ltd. Stable lipid emulsion
US6077545A (en) * 1995-10-30 2000-06-20 Matrix Pharmaceuticals, Inc. Process and composition for therapeutic cisplatin (CDDP)

Also Published As

Publication number Publication date
EA200200217A1 (ru) 2002-08-29
BG106446A (bg) 2002-09-30
ATE269094T1 (de) 2004-07-15
BR0012796A (pt) 2002-04-30
EA004587B1 (ru) 2004-06-24
WO2001007058A3 (en) 2001-07-26
GEP20033046B (en) 2003-08-25
CN1630524A (zh) 2005-06-22
US6572884B1 (en) 2003-06-03
NO20020394L (no) 2002-02-28
YU13302A (sh) 2005-03-15
DE60011625D1 (de) 2004-07-22
HUP0202269A3 (en) 2004-11-29
IL147786A0 (en) 2002-08-14
CZ2002268A3 (cs) 2002-07-17
AU778852B2 (en) 2004-12-23
EP1204417B1 (en) 2004-06-16
IN186588B (tr) 2001-10-06
DE60011625T2 (de) 2005-07-07
EP1204417A2 (en) 2002-05-15
CA2379815A1 (en) 2001-02-01
ZA200201548B (en) 2004-01-28
NZ517502A (en) 2003-07-25
ES2223571T3 (es) 2005-03-01
HUP0202269A2 (en) 2002-10-28
PL352577A1 (en) 2003-08-25
JP2003505424A (ja) 2003-02-12
MXPA02002174A (es) 2005-04-11
AP2002002384A0 (en) 2002-03-31
NO20020394D0 (no) 2002-01-25
CN100384436C (zh) 2008-04-30
KR20020063839A (ko) 2002-08-05
AU6863900A (en) 2001-02-13
WO2001007058A2 (en) 2001-02-01

Similar Documents

Publication Publication Date Title
KR880004808A (ko) 항신생 활성을 갖는 제약 조성물
KR950703965A (ko) 외상 손상과 관련된 신경학적 병변의 치료에서 라모트리진의 적용(application of lamotrigine in the treatment of neurological lesions related to traumatic injuries)
ATE146674T1 (de) Pharmazeutische zusammensetzung zur rektalen verabreichung von wirkstoffen mit topischer medizinischer wirkung im dickdarmniveau
ATE270544T1 (de) Halbfeste arzneizubereitung enthaltend isotretinoin
KR900002784A (ko) 항종양치료에 사용하기 위한 약제학적 결합제제
ES2075202T3 (es) Nuevas arilpiridazinas, su preparacion, su utilizacion, y medicamentos que las contienen.
BR0215240A (pt) Derivados de calcona e seu uso no tratamento de doenças
BR0211289A (pt) Derivados de dolastatina 10
BRPI0206636B8 (pt) composição e atividade antiviral de derivados de piperazina azaindoloxoacéticos substituídos, composições farmacêuticas que os contêm e usos
TR200200521T2 (tr) Parenteral cisplatin emülsiyonu.
KR960700054A (ko) 파킨슨씨 병 및 파킨슨 증후군의 치료에 리루졸의 이용(application of riluzole in the treatment of parkinson's disease and parkinsonian syndromes)
ATE464883T1 (de) Geschmacksabdeckende formulierung mit einer retardierten wirkstoffformulierung und/oder schnell löslichem cyclodextrin
ATE495793T1 (de) Antitumorzusammensetzungen welche ecteinascidin 743 enthalten
BRPI0313286A2 (pt) Composição e atividade antiviral de derivados de piperazina azaindoloxoacético substituìda
UY27018A1 (es) Derivados de la pirimidina
BG93114A (bg) Производни на бензонафтиридин-1,8 ,методи за получаването им и състави които ги съдържат
DE50010285D1 (de) Verwendung von polycyclischen 2-amino-thiazol systemen zur herstellung von medikamenten zur behandlung von fettstoffwechselstörungen, obesitas und typ ii diabetes
BR9807444A (pt) Produto antimicrobial
TR200003451T2 (tr) Pirimidin-Aminometil-Piridin Türevleri, Hazırlanmaları ve helikobakter bakterinin kontrolünde kullanımları
NO975790L (no) Anvendelse av allylaminderivater slik som terbinafin, i fremstillingen av et medikament for behandling av helikobacterpylori-infeksjonsassosierte sykdommer
AU8008401A (en) Amphotericin b structured emulsion
EP0937457A4 (en) MEDICINE AGAINST ALLERGIC DERMATITIS
KR910004186A (ko) 제약학적 배합물
KR870008885A (ko) 2-알콕시-n(1-아자비사이클로 [2,2,2] 옥트-3-일) 벤즈 아미드-n-옥사이드를 사용하여 구토증을 억제하는 방법
DE59903977D1 (de) Imidazotriazolopyrimidine als arzneimittel mit adenosinantagonistischer wirkung